These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 8586470)

  • 1. Nitric oxide donors induce extrusion of cyclic GMP from isolated human blood platelets by a mechanism which may be modulated by prostaglandins.
    Radziszewski W; Chopra M; Zembowicz A; Gryglewski R; Ignarro LJ; Chaudhuri G
    Int J Cardiol; 1995 Oct; 51(3):211-20. PubMed ID: 8586470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo microdialysis study of a specific inhibitor of soluble guanylyl cyclase on the glutamate receptor/nitric oxide/cyclic GMP pathway.
    Fedele E; Jin Y; Varnier G; Raiteri M
    Br J Pharmacol; 1996 Oct; 119(3):590-4. PubMed ID: 8894183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. YC-1 inhibited human platelet aggregation through NO-independent activation of soluble guanylate cyclase.
    Wu CC; Ko FN; Kuo SC; Lee FY; Teng CM
    Br J Pharmacol; 1995 Oct; 116(3):1973-8. PubMed ID: 8640334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Production and role of extracellular guanosine cyclic 3', 5' monophosphate in sodium uptake in human proximal tubule cells.
    Sasaki S; Siragy HM; Gildea JJ; Felder RA; Carey RM
    Hypertension; 2004 Feb; 43(2):286-91. PubMed ID: 14718358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of cGMP by soluble and particulate guanylyl cyclases in cultured human airway smooth muscle.
    Hamad AM; Range S; Holland E; Knox AJ
    Am J Physiol; 1997 Oct; 273(4):L807-13. PubMed ID: 9357856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of oxyhaemoglobin to explore the events underlying inhibition of platelet aggregation induced by NO or NO-donors.
    Salvemini D; Radziszewski W; Korbut R; Vane J
    Br J Pharmacol; 1990 Dec; 101(4):991-5. PubMed ID: 1707709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Positive and negative inotropic effects of NO donors in atrial and ventricular fibres of the frog heart.
    Chesnais JM; Fischmeister R; Méry PF
    J Physiol; 1999 Jul; 518 ( Pt 2)(Pt 2):449-61. PubMed ID: 10381591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of some cyclooxygenase inhibitors on the increase in guanosine 3':5'-cyclic monophosphate induced by NO-donors in human whole platelets.
    Failli P; Cecchi E; Tosti-Guerra C; Mugelli A; Laffi G; Zilletti L; Giotti A
    Br J Pharmacol; 1998 Apr; 123(7):1457-63. PubMed ID: 9579743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic interaction of adenylate cyclase activators and nitric oxide donor SIN-1 on platelet cyclic AMP.
    Fisch A; Michael-Hepp J; Meyer J; Darius H
    Eur J Pharmacol; 1995 May; 289(3):455-61. PubMed ID: 7556414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Possible role of Na(+)-K(+)-ATPase in the regulation of human corpus cavernosum smooth muscle contractility by nitric oxide.
    Gupta S; Moreland RB; Munarriz R; Daley J; Goldstein I; Saenz de Tejada I
    Br J Pharmacol; 1995 Oct; 116(4):2201-6. PubMed ID: 8564249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of guanylyl cyclase, protein kinase A and Na+ K+ ATPase in relaxations of bovine isolated bronchioles induced by GEA 3175, an NO donor.
    Elmedal Laursen B; Mulvany MJ; Simonsen U
    Pulm Pharmacol Ther; 2006; 19(3):179-88. PubMed ID: 16023394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence that different mechanisms underlie smooth muscle relaxation to nitric oxide and nitric oxide donors in the rabbit isolated carotid artery.
    Plane F; Wiley KE; Jeremy JY; Cohen RA; Garland CJ
    Br J Pharmacol; 1998 Apr; 123(7):1351-8. PubMed ID: 9579730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of nitric oxide (NO) and NO donors on the membrane conductance of circular smooth muscle cells of the guinea-pig proximal colon.
    Watson MJ; Bywater RA; Taylor GS; Lang RJ
    Br J Pharmacol; 1996 Aug; 118(7):1605-14. PubMed ID: 8842421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic cyclic GMP formation is regulated by similar factors that modulate activation of purified hepatic soluble guanylate cyclase.
    Wood KS; Ignarro LJ
    J Biol Chem; 1987 Apr; 262(11):5020-7. PubMed ID: 2435723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of nitrovasodilators on platelet cyclic nucleotide levels in rabbit blood; role for cyclic AMP in synergistic inhibition of platelet function by SIN-1 and prostaglandin E1.
    Bowen R; Haslam RJ
    J Cardiovasc Pharmacol; 1991 Mar; 17(3):424-33. PubMed ID: 1711604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natriuretic peptides and nitric oxide stimulate cGMP synthesis in different cellular compartments.
    Piggott LA; Hassell KA; Berkova Z; Morris AP; Silberbach M; Rich TC
    J Gen Physiol; 2006 Jul; 128(1):3-14. PubMed ID: 16769793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calcium channel activation facilitated by nitric oxide in retinal ganglion cells.
    Hirooka K; Kourennyi DE; Barnes S
    J Neurophysiol; 2000 Jan; 83(1):198-206. PubMed ID: 10634867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nitric oxide-donating properties of mesoionic 3-aryl substituted oxatriazole-5-imine derivatives.
    Kankaanranta H; Rydell E; Petersson AS; Holm P; Moilanen E; Corell T; Karup G; Vuorinen P; Pedersen SB; Wennmalm A; Metsä-Ketelä T
    Br J Pharmacol; 1996 Feb; 117(3):401-406. PubMed ID: 8821526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tonic inhibitory action by nitric oxide on spontaneous mechanical activity in rat proximal colon: involvement of cyclic GMP and apamin-sensitive K+ channels.
    Mulè F; D'Angelo S; Serio R
    Br J Pharmacol; 1999 May; 127(2):514-20. PubMed ID: 10385253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition by nitric oxide-donors of human polymorphonuclear leucocyte functions.
    Moilanen E; Vuorinen P; Kankaanranta H; Metsä-Ketelä T; Vapaatalo H
    Br J Pharmacol; 1993 Jul; 109(3):852-8. PubMed ID: 8395300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.